Neurol. praxi. 2012;13(2):68-71

New clinical criteria for diagnosing Alzheimer,s disease after 27 years

doc.MUDr.Irena Rektorová, Ph.D.1,2
1 Centrum pro kognitivní poruchy při 1. neurologické klinice LF MU a FN u sv. Anny, Brno
2 Vědecká skupina Aplikované neurovědy, CEITEC MU, Brno

In this review article the new diagnostic guidelines for Alzheimer’s disease are reported. The recommended biomarkers that confirm the

AD pathophysiological process are listed, however the use of these biomarker tests has not yet been advocated for routine diagnostic

purposes at present time.

Keywords: Alzheimer’s disease, diagnostic criteria, biomarkers

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rektorová I. New clinical criteria for diagnosing Alzheimer,s disease after 27 years. Neurol. praxi. 2012;13(2):68-71.
Download citation

References

  1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 270-279. Go to original source... Go to PubMed...
  2. Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, Sorbi S, Scheltens P. EFNS Scientist Panel on Dementia. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 2010; 17: 1236-1248. Go to original source... Go to PubMed...
  3. Maetzler W, Reimold M, Liepelt I, Solbach C, Leyhe T, Schweitzer K, Eschweiler GW, Mittelbronn M, Gaenslen A, Uebele M, Reischl G, Gasser T, Machulla HJ, Bares R, Berg D. [11C] PIB binding in Parkinson's disease dementia. Neuroimage 2008; 39: 1027-1033. Go to original source... Go to PubMed...
  4. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. Go to original source... Go to PubMed...
  5. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-269. Go to original source... Go to PubMed...
  6. Rektorová I. Neurodegenerativní demence. Cesk Slov Neurol N 2009; 105: 97-109.
  7. Rektorová I. Screeningové škály pro hodnocení demence. In: Rektorová I, Baláž M, Bareš M, Bočková M, Dufek M, Košťálová M, Reif M (eds.). Neurol. praxi 2011; 12(Suppl G): 37-45.
  8. Ressner P, Hort J, Rektorová I, Bartoš A, Rusina R, Línek V, Sheardová K. Doporučené postupy pro diagnostiku Alzheimerovy nemoci a ostatních demencí. Neurol. praxi 2009; 10: 237-241.
  9. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 280-292. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.